Interactive Voice-Based Administration of the PHQ-9
1 other identifier
interventional
40
1 country
1
Brief Summary
This study investigates a new delivery method for the Patient Health Questionnaire - 9 (PHQ-9), a clinically accepted tool for diagnosing major depressive disorder. The new tool records auditory responses to the assesment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable major-depressive-disorder
Started Nov 2020
Shorter than P25 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2020
CompletedFirst Posted
Study publicly available on registry
October 30, 2020
CompletedStudy Start
First participant enrolled
November 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedJuly 8, 2021
July 1, 2021
8 months
October 26, 2020
July 6, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
PHQ-9 Total Scores
Measure for Major Depressive Disorder from questionnaire responses
Immediate
User Experience Survey
26 item questionnaire tracking user experience
Immediate
Study Arms (2)
Paper Baseline
EXPERIMENTALHalf of the participants will complete the PHQ-9 in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the PHQ-9 on the Mirror device equipped with Amazon Alexa.
Mirror Baseline
EXPERIMENTALHalf of the participants will complete the PHQ-9 on the Mirror device equipped with Amazon Alexa at their first appointment. At their second appointment 1-month later, they will will complete the PHQ-9 in the traditional paper format.
Interventions
The intervention we will be using is a new delivery system of the PHQ-9 using an Amazon Alexa equipped Mirror device. This Mirror device is similar to a smart television with a mirror interface. The device records auditory responses to the PHQ-9. We will be comparing the responses from the Mirror device to those given on the clinically established paper format.
Eligibility Criteria
You may qualify if:
- Newly admitted patients to the Oklahoma State University Behavioral Medicine Clinic
You may not qualify if:
- Vulnerable populations, such as children (i.e., minors or individuals under the legal age of consent) and individuals who are incarcerated (i.e., prisoners), will be excluded.
- Individuals who are not their own guardian (i.e., those suffering from severe disabilities) will also be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OSU Behavioral Health Clinic
Tulsa, Oklahoma, 75135, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Beaman, D.O.
Oklahoma State University Center for Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The study will be counterbalanced with no masking components
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2020
First Posted
October 30, 2020
Study Start
November 3, 2020
Primary Completion
June 18, 2021
Study Completion
July 31, 2021
Last Updated
July 8, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share
Aggregate data and findings will be posted on ClinicalTrials.gov.